NEW YORK (GenomeWeb News) – US Food and Drug Administration Commissioner Margaret Hamburg and National Institutes of Health Director Francis Collins presented their vision for the future of personalized medicine in a perspectives article appearing online in the New England Journal of Medicine yesterday.

In it they explained that while researchers are inching closer to personalized medicine — identifying genetic variants involved in diagnosing disease and predicting treatment response — there are still a range of significant scientific and policy issues that need to be dealt with before personalized medicine reaches its full potential.